Glycolytic and fatty acid oxidation genes affect the treatment and prognosis of liver cancer

Figure 9 Prediction of the efficacy of immune checkpoint blockade therapy and chemotherapy drugs in International Cancer Genome Consortium datasets. A: Distribution of Tumour Immune Dysfunction and Exclusion scores in high-risk subtype of LIRI-JP vs low-risk subtype of LIRI-JP; B: Box plot shows samples with response if immune checkpoint blockade therapy; C: Half-maximum inhibitory concentration of clinical anti-cancer drugs forecasted by Genomics of Drug Sensitivity in Cancer.